Analyst Information
Edward TenthoffSr Research Analyst![]() Ted Tenthoff is a managing director and senior research analyst at Piper Sandler, focused on the drug discovery sector of the biotech industry. In April 2013 and 2015, Tenthoff moderated panels at the International Adult Stem Cell Conference at the Vatican. He was ranked No. 2 stock picker in biotechnology by the 2012 Wall Street Journal "Best on the Street" survey and was ranked No. 1 stock picker for the life science tools and services sector in the 2006 Starmine Analyst Awards. Prior to joining Piper Sandler in 2003, he covered the genomics sector at Robertson Stephens & Company, and was a medical technology analyst at Lehman Brothers. Tenthoff received a bachelor’s degree in international relations from the University of Pennsylvania. |
Universe Coverage: Healthcare: Biotechnology | |
AGLE | Aeglea Biotherapeutics, Inc. |
ALNY | Alnylam Pharmaceuticals, Inc. |
APVO | Aptevo Therapeutics Inc. |
APTO | Aptose Biosciences, Inc. |
ARAV | Aravive, Inc. |
ARWR | Arrowhead Pharmaceuticals |
ARVN | Arvinas Inc. |
ASLN | Aslan Pharmaceuticals Ltd. |
LIFE | aTyr Pharma, Inc. |
BCYC | Bicycle Therapeutics Ltd. |
IPSC | Century Therapeutics, Inc. |
CCXI | ChemoCentryx, Inc. |
CRSP | CRISPR Therapeutics AG |
DYN | Dyne Therapeutics, Inc. |
ELOX | Eloxx Pharmaceuticals, Inc. |
FATE | Fate Therapeutics, Inc. |
FULC | Fulcrum Therapeutics, Inc. |
GMDA | Gamida Cell Ltd. |
INFI | Infinity Pharmaceuticals, Inc. |
JNCE | Jounce Therapeutics, Inc. |
KRON | Kronos Bio, Inc. |
KYMR | Kymera Therapeutics, Inc. |
LEGN | Legend Biotech Corporation |
MIST | Milestone Pharmaceuticals, Inc. |
MRNA | Moderna, Inc. |
GLUE | Monte Rosa Therapeutics, Inc. |
NXTC | NextCure, Inc. |
OMGA | Omega Therapeutics, Inc. |
OPK | OPKO Health, Inc. |
PNT | POINT Biopharma Global Inc. |
PSTX | Poseida Therapeutics, Inc. |
PRTC | PureTech Health Plc |
RAPT | Rapt Therapeutics, Inc. |
MCRB | Seres Therapeutics, Inc. |
STRO | Sutro Biopharma, Inc. |
SYBX | Synlogic, Inc. |
SYRS | Syros Pharmaceuticals, Inc. |
TPST | Tempest Therapeutics, Inc. |
XNCR | Xencor, Inc. |
YMTX | Yumanity Therapeutics Inc. |